 |
||||||||
|
Influenza > For Providers, Laboratories
On this page:
Influenza Disease and Prevention
Antiviral Course Tracking Forms As outlined in the state’s Pandemic Influenza Emergency Management Plan, to ensure proper tracking of antiviral medication throughout the state, treatment centers are responsible for tracking how many antiviral courses they receive, redistribute, dispense, and to whom. Treatment centers are also responsible for reporting this information to the state. The Food and Drug Administration's (FDA) Vaccine and Related Biological Products Advisory Committtee (VRBPRAC) met on February 21, 2008, to select the influenza strains for the composition of the influenza vaccine for use in the 2008-2009 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characterizations, serological responses to 2007/2008 vaccines and the availablity of candidate strains and reagents. The panel reccomended that the vaccines to be used in the 2008-2009 influenza season in the U.S. contain the following:
For more information visit the FDA's flu page
Billing, Coding and Dose Reporting Flu information for specific groups
Vaccination of health-care workers (HCWs) has been shown to reduce transmission of influenza and absenteeism among HCWs, prevent mortality in their patients, and result in financial savings to worksites. Influenza vaccination coverage among HCWs in the United States, however, remains dismally low.
|
||||||||
